Millions may be getting the wrong cholesterol test

LDL cholesterol is the number almost everyone gets back from a standard lipid panel, and the number most treatment decisions have historically been based on. A 2026 analysis is part of a growing body of evidence arguing that LDL, on its own, systematically misclassifies risk for a meaningful share of patients — and that ApoB is the more reliable number to act on.

Why LDL alone can mislead

LDL cholesterol measures the amount of cholesterol carried inside LDL particles — but it does not directly count the particles themselves, and particle number is what actually drives atherosclerotic plaque formation. In people with insulin resistance, high triglycerides or metabolic syndrome, it is common to have a normal-looking LDL number while carrying a high number of small, dense, cholesterol-depleted LDL particles — each one still capable of lodging in an artery wall. ApoB, a protein present on the surface of every atherogenic particle (LDL, VLDL and Lp(a) included), counts particles directly rather than inferring them from cholesterol content.

Who this discordance affects most

The mismatch between LDL and ApoB is not evenly distributed — it is most common in exactly the population that also tends to be undertreated: people with elevated triglycerides, prediabetes, type 2 diabetes, or a high-carbohydrate dietary pattern. For these groups, a "normal" LDL result can create false reassurance while the ApoB-measured particle burden remains elevated.

LDL cholesterol tells you how much cholesterol is in your LDL particles. ApoB tells you how many particles you actually have. For a meaningful share of people, those two numbers disagree — and it is the particle count that predicts cardiovascular risk.

What to actually do with this

ApoB is a standard, inexpensive addition to most lipid panels — it does not require a specialist referral, just a specific request to your clinician or lab. If your LDL and ApoB tell the same story, nothing changes. If they disagree, ApoB is the number the evidence increasingly says to act on, particularly if you also run high triglycerides or any marker of insulin resistance.

Misi surfaces ApoB alongside LDL automatically when it is present in an uploaded lab panel, and flags LDL/ApoB discordance directly rather than letting a reassuring LDL number sit unchallenged next to a concerning ApoB one.

Misi is a coaching and wellness platform, not a medical service. Cholesterol-lowering treatment decisions, including whether to start or adjust medication, should be made with your physician.